ARCHIVES

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

This article is from The Cancer Letter archive.

Vol. 31 No. 35 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

NAS Committee Urges Greater Rewards For Interdisciplinary Research.

January 21, 2005

Cancer Panel Statement On Access To Cancer Care.

October 6, 2000

The Cancer Letter Takes Summer Publication Break.

August 2, 2002

Master’s Program In Nurse Oncology Kept Alive; Final Decisions In February

October 21, 1977

Centers Can Collaborate Well with Industry, Albert LoBuglio Says

May 7, 1999

In Brief: Hellman to Leave Memorial This Fall For Position As Dean, Vice President at Univ. Of Chicago

April 8, 1988